9-99153794-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004612.4(TGFBR1):c.*4489T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0695 in 206,986 control chromosomes in the GnomAD database, including 619 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.071 ( 466 hom., cov: 33)
Exomes 𝑓: 0.066 ( 153 hom. )
Consequence
TGFBR1
NM_004612.4 3_prime_UTR
NM_004612.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.28
Publications
15 publications found
Genes affected
TGFBR1 (HGNC:11772): (transforming growth factor beta receptor 1) The protein encoded by this gene forms a heteromeric complex with type II TGF-beta receptors when bound to TGF-beta, transducing the TGF-beta signal from the cell surface to the cytoplasm. The encoded protein is a serine/threonine protein kinase. Mutations in this gene have been associated with Loeys-Dietz aortic aneurysm syndrome (LDAS). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
TGFBR1 Gene-Disease associations (from GenCC):
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Loeys-Dietz syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- Loeys-Dietz syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P
- multiple self-healing squamous epitheliomaInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 9-99153794-T-C is Benign according to our data. Variant chr9-99153794-T-C is described in ClinVar as Benign. ClinVar VariationId is 364185.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0823 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TGFBR1 | NM_004612.4 | c.*4489T>C | 3_prime_UTR_variant | Exon 9 of 9 | ENST00000374994.9 | NP_004603.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TGFBR1 | ENST00000374994.9 | c.*4489T>C | 3_prime_UTR_variant | Exon 9 of 9 | 1 | NM_004612.4 | ENSP00000364133.4 |
Frequencies
GnomAD3 genomes AF: 0.0709 AC: 10794AN: 152202Hom.: 467 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
10794
AN:
152202
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0658 AC: 3596AN: 54666Hom.: 153 Cov.: 0 AF XY: 0.0687 AC XY: 1751AN XY: 25470 show subpopulations
GnomAD4 exome
AF:
AC:
3596
AN:
54666
Hom.:
Cov.:
0
AF XY:
AC XY:
1751
AN XY:
25470
show subpopulations
African (AFR)
AF:
AC:
138
AN:
2464
American (AMR)
AF:
AC:
71
AN:
1552
Ashkenazi Jewish (ASJ)
AF:
AC:
216
AN:
3432
East Asian (EAS)
AF:
AC:
21
AN:
8486
South Asian (SAS)
AF:
AC:
19
AN:
458
European-Finnish (FIN)
AF:
AC:
17
AN:
122
Middle Eastern (MID)
AF:
AC:
25
AN:
362
European-Non Finnish (NFE)
AF:
AC:
2762
AN:
33262
Other (OTH)
AF:
AC:
327
AN:
4528
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
179
357
536
714
893
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0709 AC: 10799AN: 152320Hom.: 466 Cov.: 33 AF XY: 0.0714 AC XY: 5321AN XY: 74490 show subpopulations
GnomAD4 genome
AF:
AC:
10799
AN:
152320
Hom.:
Cov.:
33
AF XY:
AC XY:
5321
AN XY:
74490
show subpopulations
African (AFR)
AF:
AC:
2282
AN:
41578
American (AMR)
AF:
AC:
836
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
252
AN:
3470
East Asian (EAS)
AF:
AC:
4
AN:
5190
South Asian (SAS)
AF:
AC:
174
AN:
4828
European-Finnish (FIN)
AF:
AC:
1267
AN:
10616
Middle Eastern (MID)
AF:
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5720
AN:
68012
Other (OTH)
AF:
AC:
164
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
532
1064
1597
2129
2661
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
122
244
366
488
610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
58
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
May 15, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Loeys-Dietz syndrome 1 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Loeys-Dietz syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.